Latest News & Features
Asia-Pacific
Mitsubishi Tanabe has agreed to acquire NeuroDerm, a clinical stage pharmaceutical company, for $1.1 billion. 25 July 2017
Americas
The Patent Trial and Appeal Board has sided with UCB in an inter partes review brought by Mylan. 24 July 2017
Americas
Amphastar Pharmaceuticals has succeeded in a jury trial against biotech company Momenta Pharmaceuticals and Sandoz, providing Amphastar with a way out of a patent suit over a blood thinning drug. 24 July 2017
Americas
The US Food and Drug Administration has tentatively approved a Merck biosimilar, pending resolution of a patent dispute. 21 July 2017
Americas
Abbott Laboratories has settled its dispute with a Florida-based pharmacy accused of selling grey market goods. 21 July 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling by the International Trade Commission on dental implant patents. 20 July 2017
Americas
Law firm BakerHostetler has hired a new partner to join its Cincinnati and Atlanta offices. 20 July 2017
Americas
Biopharmaceutical company Sarepta Therapeutics and biotech firm Biomarin Pharmaceutical have settled a patent dispute and entered into a licence agreement. 20 July 2017
Americas
A California district court has awarded Gilead Sciences $13.8 million in attorneys’ fees in a patent dispute against Merck & Co, Merck Sharp & Dohme and Isis Pharmaceuticals. 20 July 2017
Americas
A Michigan district court has ruled in favour of Stryker in a patent case against medical device company Zimmer after it was found to have infringed three patents belonging to Stryker. 20 July 2017